# Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

> **NCT01142414** · PHASE3 · WITHDRAWN · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC**

## Conditions studied

- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** panitumumab
- **DRUG:** cisplatin
- **DRUG:** fluorouracil
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** quality-of-life assessment
- **RADIATION:** 3-dimensional conformal radiation therapy
- **RADIATION:** intensity-modulated radiation therapy

## Key facts

- **NCT ID:** NCT01142414
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01142414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01142414, "Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT01142414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*